Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Realigning Portfolio Allocation with Nicholas Mersch November 14, 2025 Glencore Bets on China’s Aluminum Boom with Chuangxin Listing Investment November 14, 2025 Senior Loan Facility Refinanced with Nebari November 14, 2025